Seth Cohen, Ph.D., is a scientific founder and advisor of Forge Therapeutics and a Professor and former Chair of the Department of Chemistry and Biochemistry at the University of California, San Diego. Dr. Cohen is a world leading authority on the design, synthesis, and evaluation of inhibitors of metalloproteins and has successfully designed novel ligands that better target the metal active site of proteins for therapeutic uses. He was a NIH postdoctoral fellow at M.I.T., earned a Ph.D. in Chemistry at the University of California, Berkeley and a B.S. in Chemistry and a B.A. in Political Science at Stanford University. He has published >150 research papers and given dozens of invited lectures. He sits on numerous boards and review panels for journals, federal agencies, and non-profit organizations. His research and teaching accomplishments have been recognized as a fellow of the American Association for the Advancement of Science, American Chemical Society, and the Royal Society of Chemistry (U.K.). He also served as the AAAS Roger Revelle fellow (2008-2009) working at the White House Office of Science and Technology Policy (OSTP). He is currently the Chair of the Department of Chemistry and Biochemistry at the University of California, San Diego and is a scientific founder of Cleave Biosciences.